Clinical trials
Phase 1/2 Breast Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 1 |
| Ensem Therapeutics | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Joseph Sparano | 1 |
| Stemline Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Diseases | 5 |
| Breast Neoplasms | 5 |
| Neoplasms | 3 |
| Neoplasms by Site | 3 |
| Endometrial Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Hereditary Sensory and Autonomic Neuropathies | 2 |
| Ovarian Neoplasms | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Uterine Cervical Neoplasms | 2 |
Trials
Showing 76 to 5 of 5. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.